Down More Than 45%: 2 Buy-Rated Stocks Snatch Up Now

NASDAQ: RAMP | LiveRamp Holdings, Inc.  News, Ratings, and Charts

RAMP – Concerns over high inflation, the Fed’s hawkish monetary policy, and the potential for the economy to slide into a recession have caused the market to suffer a significant correction of late. But the current downtrend could be a great opportunity to scoop up shares of quality companies LiveRamp Holdings (RAMP) and Herbalife Nutrition (HLF), which are down more than 45% in price. These stocks are rated Buy in our proprietary rating system.

The major stock market indexes have suffered a massive correction lately, with S&P 500 down more than 20% from its peak in January. Geopolitical uncertainties, rising oil prices, worsening supply chain disruptions, and the Fed’s intention to combat surging inflation by raising interest rates several times this year have rattled the stock market.

Furthermore, the increasing odds of the U.S. economy slipping into a recession have also perplexed investors. Last week, Wells Fargo CEO and president Charlie Scharf said it would be difficult for the U.S. to avoid “some kind of recession.”

So, amid current market uncertainty, we think it could be wise to scoop the shares of fundamentally sound companies LiveRamp Holdings, Inc. (RAMP) and Herbalife Nutrition Ltd. (HLF), which are down more than 45% year-to-date. These stocks could rebound in the coming months based on their solid growth attributes. They are rated Buy in our proprietary POWR Ratings System.

LiveRamp Holdings, Inc. (RAMP)

Headquartered in San Francisco, RAMP, a technology company, offers enterprise data connectivity platform solutions in the United States, Europe, and Asia-Pacific. The company offers RampID, a true people-based identifier.

In February, RAMP announced that Adobe Advertising Cloud now supports RampID™ across channels, including desktop display, desktop video, mobile web, mobile in-app, connected TV (CTV), native, and audio. Advertisers can unlock people-based audience targeting, frequency capping, first- and third-party data activation, delivery reporting, supply-side integrations, exposure logs, and measurement support through Adobe’s Advertising Solutions Group (ASG).

For the fourth quarter, ending March 31, 2022, RAMP’s revenues increased 18.9% year-over-year to $141.73 million. Its gross profit improved 25.3% from its year-ago value to $102.25 million, while its non-GAAP operating income amounted to $1.00 million. The company’s cash and cash equivalent increased 4.8% year-over-year to $600.16 for its fiscal year ending March 31, 2022.

Analysts expect RAMP’s revenue to increase 16.9% year-over-year to $139.15 million for the first quarter, ending June 30, 2022. The $0.24 consensus EPS estimate for the same period, represents a 72.3% improvement year-over-year. The stock has plunged 46.9% in price year-to-date.

RAMP’s POWR Ratings reflect this promising outlook. The company has an overall B rating , which translates to Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 distinct factors, each with its own weighting.

The stock also has a B grade for Value and Growth. Within the C-rated Technology – Services Industry, it is ranked #20 of 81 stocks.

To see additional POWR Ratings for Quality, Sentiment, Stability, and Momentum for RAMP, click here.

Herbalife Nutrition Ltd. (HLF)

HLF provides nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company offers products in weight management, targeted nutrition, energy, sports and fitness, and outer nutrition. The company is headquartered in Los Angeles, California.

In the first quarter, ending March 31, 2022, HLF’s worldwide net sales amounted to $1.34 billion. Its operating income came in at $153.10 million, while its adjusted net income was  $101.00 million. The company’s adjusted EPS stood at $0.99.

The  $0.98 consensus EPS estimate for the fourth quarter ending Dec. 31, 2022, represents a 71.4% improvement year-over-year. Analysts expect HLF’s revenue to increase 1.1% year-over-year to $1.33 billion for the same period. In addition, the company has an impressive earnings surprise history; it surpassed the consensus EPS estimates in three of the trailing four quarters. The stock has declined 48.6% year-to-date.

HLF’s strong fundamentals are reflected in its POWR Ratings. The stock has an overall B rating, which equates to Buy in our POWR Ratings system. HLF  also has an A grade for Quality and Value. Within the A-rated Medical – Consumer Goods industry, it is ranked #3 of 8 stocks.

In total, we rate HLF on eight distinct levels. Beyond what we have stated above, we have also given HLF grades for Stability, Sentiment, Growth, and Momentum. Get all the HLF ratings here.

Want More Great Investing Ideas?

3 Stocks to DOUBLE This Year

Top 10 Stocks for 2022

Bear Market Scare? Read Before Your Next Trade

7 SEVERELY Undervalued Stocks


RAMP shares were trading at $26.32 per share on Thursday afternoon, up $0.87 (+3.42%). Year-to-date, RAMP has declined -45.11%, versus a -14.24% rise in the benchmark S&P 500 index during the same period.


About the Author: Spandan Khandelwal


Spandan's is a financial journalist and investment analyst focused on the stock market. With her ability to interpret financial data, she aims to help investors evaluate the fundamentals of a company before investing. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
RAMPGet RatingGet RatingGet Rating
HLFGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


How Low Could Stocks Go?

The S&P 500 (SPY) is starting to test key support levels for the first time since November 2023 given continuing signs that Fed rate cuts are getting pushed further and further into the future. This begs the question of “how low could stocks go?” 44 year investment veteran Steve Reitmeister does his level best to answer that question including a trading plan and top picks to stay one step ahead of the market. Read on below for the full story...

3 Biotech Stocks to Buy to Power Through April

The biotech sector is primed for growth, fueled by a surge in FDA approvals, anticipated M&A deals, and the integration of AI in drug discovery. So, fundamentally sound biotech stocks Theratechnologies (THTX), Harmony Biosciences (HRMY), and Shionogi & Co. (SGIOY) might be solid buys in this month. Keep reading...

Check out These 3 Internet Stocks for Potential Gains

Amplified internet usage, technological advancements, and a rising digital transformation worldwide have driven the internet industry rapidly. To that end, quality internet stocks Wix.com (WIX), Tripadvisor (TRIP), and Yelp (YELP) could be solid buys now. Read on…

Top 3 Financial Services Stocks With Unstoppable Momentum

The financial services sector is set for solid growth owing to global economic trends, technological advancements making digital services more accessible, and changing consumer preferences.Therefore, investors could consider buying fundamentally strong financial services stocks Broadridge Financial Solutions (BR), Banco Macro (BMA), and Yiren Digital (YRD) as they look well-positioned to continue their momentum. Read more...

Updated 2024 Stock Market Outlook

The bull market continues to rage on with the S&P 500 (SPY) making new highs. That is the past...the question is what does the future hold? That is why 44 year investment veteran Steve Reitmeister provides this updated 2024 Stock Market Outlook to help you carve a path to outperformance the rest of the year. Read on below for the full story...

Read More Stories

More LiveRamp Holdings, Inc. (RAMP) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All RAMP News